Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patient with Type 2 Diabetes: The ADVANCE Trial.

CONCLUSIONS: Visit-to-visit variability in SBP and maximum SBP were independent risk factors for macrovascular and microvascular complications in type 2 diabetes. CLINICAL TRIAL REGISTRATION INFORMATION: http://www.clinicaltrials.gov. Unique Identifier: NCT00145925. PMID: 23926207 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23926207?dopt=Abstract

Source: Circulation - August 7, 2013 Category: Cardiology Authors: Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, Patel A, Neal B, Glasziou P, Hamet P, Mancia G, Poulter N, Williams B, Macmahon S, Chalmers J, on behalf of the ADVANCE Collaborative Group Tags: Circulation Source Type: research